2.1(top 8%)
Impact Factor
2.4(top 8%)
extended IF
95(top 4%)
H-Index
1.6K
authors
3.5K
papers
65.3K
citations
6K
citing journals
37.7K
citing authors

Most Cited Articles of Cancer Investigation

TitleYearCitations
Development of the proteasome inhibitor Velcade (Bortezomib)2004523
Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy2001439
Spontaneously occurring tumors of companion animals as models for human cancer2000369
Soy isoflavones and cancer prevention2003293
Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer2005279
Review: tubulin function, action of antitubulin drugs, and new drug development2005258
Current treatment of osteosarcoma2001247
Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents1984246
The first 1000 dendritic cell vaccinees2003245
Possible role of oxidative damage in metal-induced carcinogenesis1995242
Cell adhesion molecules: role and clinical significance in cancer2009229
The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis?1992228
Quality of life in cancer: definition, purpose, and method of measurement1993227
Suppression of tumor cell growth by anthocyanins in vitro1995221
Taxanes: a new class of antitumor agents1995218
The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells2013216
The HER-2/neu oncogene in tumors of the gastrointestinal tract2001213
Mitochondrial DNA alterations in cancer2002193
The response of the microvascular system to radiation: a review1989191
Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors1994190
Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin2011188
Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor1998184
Comprehensive criteria for assessing therapy-induced toxicity1990184
The Epidemiology of Cancer Pain2005182
Pathologic and clinical spectrum of post-thymic T-cell malignancies1984182